Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Medical Devices Market Size to Hit USD 964.90 Billion by 2030 at 6.99% CAGR – Report by Market Research Future (MRFR)

Published

on

<!– Name:DistributionId Value:8793457 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1259337 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:a85e112e-e95a-4252-8fd2-6b4fb5eae1e0 –>

New York, USA, March 22, 2023 (GLOBE NEWSWIRE) — Medical Devices Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Medical Devices Market Information By Product Type, Therapeutic Application, End User, And Region – Forecast till 2030“, the market size was valued USD 492.3 billion in 2021 and is expected to reach USD 964.90 billion by 2030 at CAGR of 6.99% during the forecast period 2022-2030

Market Scope

A medical device is an instrument, apparatus, implant, machine, tool, in vitro reagent, or similar used to diagnose, prevent, help alleviate, treat, or cure disease or other conditions. Unlike pharmaceuticals or biologics, medical devices achieve their goals through physical, structural, or mechanical action rather than chemical or metabolic action within or on the body. The medical device is used for disease and injury diagnosis, observation, prevention, and therapy. Medical devices provide several advantages by assisting people in overcoming sickness or disease and enhancing their quality of life. Due to factors like the increasing prevalence of cardiovascular illnesses, strategic moves by important market players, and other developments, cardiology is anticipated to experience considerable expansion in the medical devices market over the coming years.

The cost of caring for a patient while inpatient at a hospital is much higher, and lengthy hospital stays are linked to a greater financial burden. The need for cardiological medical equipment is also fueled by the rising prevalence and incidence of disorders, including obesity, diabetes, pressure, and high cholesterol, as people with these conditions are more prone to experience cardiac issues in their lifetime. Cardiovascular gadgets are used to identify heart conditions and treat associated health issues. More and more patients are being handled using cardiology devices, which has had an exponential impact on therapeutic and monitoring outcomes due to development in business activities and technological advancements, including the application of artificial intelligence in wearable cardiac devices. Class I and II products must have special labels and are subject to the least regulatory oversight. The things in Class III support or maintain human life. It has an endosseous implant, an external defibrillator, and a pulse generator.

Get Free Sample PDF Brochure @  https://www.marketresearchfuture.com/sample_request/2869

Report Scope:

Report Attribute Details
Market Size in 2030 USD 964.90 Billion
CAGR 6.99%
Base Year 2021
Forecast Period 2022-2030
Historical Data 2020
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Devices Type, Application and End User
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers Shift towards homecare settings is boosting the demand for portable devices
Increasing technological advancement

Competitive Landscape:

The distinguished contenders in the medical devices market are:

  • Becton, Dickinson, and Company (US)
  • Abbott (US)
  • Medtronic (Ireland)
  • Siemens AG (Germany)
  • Fresenius SE & Co. KGaA (Germany)
  • GE Healthcare (US)
  • Johnson & Johnson Services Inc (US)
  • Stryker (US)
  • Boston Scientific Corporation (US)
  • Bio-Rad Laboratories, Inc (US)

Medical Devices Market Dynamics:

Market Drivers:

Population growth, the rise in chronic diseases, the complexity of procedures, and advancements in implantation techniques are key reasons supporting the market’s expansion. In the future, the medical devices market is anticipated to rise due to rising chronic disease prevalence, increased investment in development and research by medical technology businesses, and an easy regulatory approval procedure for those devices. Throughout the projected period, the market for medical devices is anticipated to grow due to the development of brain monitoring systems and major technological advancements in the medical device sector. Moreover, rising health concerns, long-term illnesses, and rising healthcare costs have fueled the market globally.

Moreover, improvements in brain monitoring technology, major technological advancements in medical devices, and major progress in commercial elements have all been positively anticipated as driving the market expansion of the medical devices. Also, the prevalence of chronic diseases is rising globally, raising the need for effective and sophisticated treatment options that incorporate a range of diagnostic and surgical techniques. As a result, there is a growing need for medical equipment worldwide. To frequently check the condition, various portable and wearable medical gadgets may become more popular due to the anticipated rise in the number of persons with diabetes. Also, increasing product launches and the increased focus on creating technologically advanced medical equipment foster market expansion.

Market Restraints:

In the last ten years, the medical device sector has seen significant changes, including design alterations and new technology adoption. The high cost of these devices, which includes a significantly higher acquisition cost and ongoing maintenance charges, raises the entire cost of ownership of the equipment. Some more sophisticated gadgets come with several additional parts, including chips, batteries, detectors, and other accessories that must be periodically replaced. However, during the projection period, the medical devices market is projected to have growth challenges due to stringent regulations and uncertain reimbursement.

Browse In-depth Market Research Report (110 Pages) on Medical Devices: https://www.marketresearchfuture.com/reports/medical-devices-market-2869

COVID 19 Analysis

The coronavirus pandemic disrupts worldwide supply chains, but the medical device industry suffers the most. Global production has been impacted by the COVID-19 epidemic, which has also altered the working environment for many enterprises. Most businesses have increased their production capacity to satisfy the rising demand for vital goods. The COVID-19 pandemic significantly negatively influenced the whole medical equipment business, having a wide range of repercussions on the various categories. Elective and non-essential procedures were delayed or canceled due to the pandemic. However, to meet the enormous demand, the examined market that provides hospital equipment for the treatment of COVID-19, such as personal safety gear (PPE), ventilators, and regular hospital supplies, saw a boom in sales. Consider ventilators, a crucial piece of equipment.

Medical Devices Market Segmentation

The market includes gastrointestinal surgery, general surgery, and diagnostic imaging by therapeutic application.

By end user, the market includes hospitals & clinics and diagnostic centers & research laboratories.

By Devce type, the market includes cardiac monitoring, diagnostic, and drug delivery.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=2869

Medical Devices Market Regional Insights

Due to factors including the increasing incidence of long-term illnesses, high healthcare costs, and the presence of major players, North America is anticipated to drive the medical devices market for the duration of the forecast. Also, the forecasted market expansion is projected to be accelerated by the growing geriatric population. In turn, this is projected to boost demand for diagnostic imaging and other surgical procedures, fuel the growth of medical devices, and drive the market to expand during the forecast period.

The growing elderly population is more likely to develop chronic diseases like respiratory, cardiopulmonary, and orthopedic illnesses, increasing the demand for these procedures. Asia-Pacific is thought to have the fastest-growing market for medical devices. This results from factors like expanding health systems, government initiatives, and an increasing number of patients with chronic illnesses like cancer, osteoporosis, arthritis, cancer, and chronic renal disease.

Discover more research Reports on Healthcare Industry by Market Research Future:

Wearable Medical Device Market Size, Trends By Type (Activity Monitors, Smart Watches, Smart Clothing, Patches), Device Type (Diagnostic &amp; Monitoring Devices, Therapeutic Devices), Application (Sports Academies and Fitness, Remote Patient Monitoring, Home Healthcare), Distribution Channel (Pharmacies, Online Channel, Hypermarkets) – Forecast till 2030

Smart Medical Devices Market Research Report: By Type (On-body (adhesive patch), Off-body (belt clip), Hand-held), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Pressurized Gas, Others), By Application (Oncology, Diabetes, Auto-Immune Disorders, Infectious Diseases, Others) and By End-Use (Hospital, Clinic, Home Care Settings, Others) – Forecast to 2027

Africa Medical Devices Market Information By Product Type (Monitoring Devices, Diagnostic Devices, Diagnostic Molecular Devices, Drug Delivery Devices, Surgical Devices, Bio Implants & Stimulation Devices, and Automation & Robotics), By Therapeutic Application (General Surgery, Diagnostic Imaging, Respiratory, Orthopedics, Cardiovascular, Dental, Neurology, Ophthalmology, Ear-Nose-Throat (ENT), & Nephrology and Urology), By End User (Hospitals, and Ambulatory & Home), and By Country (South Africa, Egypt, and Rest of Africa)—Forecast till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

A medical device is an instrument, apparatus, implant, machine, tool, in vitro reagent, or similar used to diagnose, prevent, help alleviate, treat, or cure disease or other conditions. Unlike pharmaceuticals or biologics, medical devices achieve their goals through physical, structural, or mechanical action rather than chemical or metabolic action within or on the body


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Tencent Announces Winners of Flagship CarbonX Program to Combat Climate Change

Published

on

tencent-announces-winners-of-flagship-carbonx-program-to-combat-climate-change

SHENZHEN, China, May 23, 2024 /PRNewswire/ — Tencent (00700.HK) is awarding 13 exceptional teams that won the first phase of its groundbreaking CarbonX Program, which is aimed at boosting promising new climate technologies. The winners, which emerged from a pool of 30 finalists and more than 300 initial applications, will receive a total of around RMB 100 million (US$14 million) in financial support from Tencent. It showcases the company’s commitment to driving sustainable social innovations in the fight against climate change.

CarbonX was launched in March 2023 to advance the next generation of low-carbon technologies. Tencent has committed RMB 200 million (US$28 million) in catalytic funding over the next three years to innovative ideas that might otherwise languish or fail to gain traction.
CarbonX’s first phase focused on carbon capture, utilization, and storage (CCUS), as well as technology-based carbon removal. These solutions were chosen for their unique ability to curb emissions from hard-to-abate industries such as steel and cement, mitigate the continued reliance on fossil fuels, and reduce legacy emissions created from decades of industrialization.
Backed by Tencent’s mission of Tech for Good and an alliance of like-minded industry partners, CarbonX aims to help these cutting-edge technologies make the leap from the research or early startup stage to commercial scale. The ultimate goal is supporting them in making a significant impact toward the targets outlined in the Paris Agreement, which includes a 45 percent reduction in emissions by 2030 and achieving net-zero emissions by 2050.
Dr. Hao Xu, Tencent’s Vice President of Sustainable Social Value and Head of Tencent’s Carbon Neutrality Lab, said: “Technology innovation serves as the driving force to accelerate our progress toward achieving carbon neutrality. CarbonX program is aimed at fostering the growth of these technologies, driving positive impact across society, and laying the groundwork for a more sustainable future.”
Professor Jerry Yan, Chair Professor of the Hong Kong Polytechnic University and Co-chairman of the CarbonX expert committee, said: “To pave the path for a greener economy, we must champion the development of cutting-edge low-carbon technologies. Just as solar and wind power were nurtured in their infancy, emerging solutions like CCUS and tech-based carbon removal demand our early support.”
The program assembled a panel of experts from academia, industries, and the investor community as the jury, and welcomed submissions from diverse participants across three distinct tracks:
CarbonX Lab: Designed to incubate research institutions, universities, or labs that bring in game-changing climate solutionsCarbonX Accelerator: Designed to accelerate the growth of climate-tech startups that exhibit commercialization potentialCarbonX Infrastructure: Designed to support capacity building to facilitate industry developmentThe finalists comprise four projects from the Lab track, six from the Accelerator track, and three from the Infrastructure track. These projects explore innovative solutions, such as using steel slag to capture and store carbon directly from furnace exhaust, converting CO2 into sustainable aviation fuel and valuable chemicals through electrochemical reactions or microorganisms, and employing new approaches to directly capture CO2 from the atmosphere with the hope of slashing the cost to less than US$150 per ton.
Meanwhile, Tencent is also collaborating with Tsinghua University to develop a comprehensive system of Measure, Reporting and Verification (MRV) tools to accurately gauge progress toward decarbonization.
Aside from receiving financial and advisory support, several projects will also have the opportunity to collaborate with industry partners and test their research beyond the laboratory setting.
Building upon the success of the first phase, Tencent is poised to launch the second iteration of CarbonX globally as early as later this year in pursuit of early-stage climate tech innovation.

View original content:https://www.prnewswire.co.uk/news-releases/tencent-announces-winners-of-flagship-carbonx-program-to-combat-climate-change-302153596.html

Continue Reading

Artificial Intelligence

NEXCOM Delivers Exceptional Performance in Edge AI Video Analytics

Published

on

nexcom-delivers-exceptional-performance-in-edge-ai-video-analytics

TAIPEI, May 23, 2024 /PRNewswire/ — NEXCOM, a leading supplier of network solutions, published AI and storage performance test results of its NSA 7160R: high-performance Edge server. NSA 7160R is powered by dual Intel® Xeon® Scalable processors for high computing, and enhanced with DDR5 memory, high-bandwidth PCIe Gen5 LAN modules, and high-capacity NVMe storage modules. The test results show the efficiency of the NSA 7160R in processing edge video server workloads and were explained in the accompanying paper. 

Edge AI Is the Future
With the rise of smart cities, processing data from cloud to the edge is becoming increasingly critical. Imagine the surge of visual data from ubiquitous security cameras – that information needs real-time analysis right where it’s collected. This is just the tip of the iceberg. As artificial intelligence permeates our lives, certain AI tasks will also need edge computing for efficient, lightning-fast performance. The key is to avoid bottlenecks in the data center by keeping things localized and streamlined.
Your Turnkey Solution Awaits
When it comes to Edge video servers, you need top-notch hardware and software that can handle all the “heavy lifting”. To speed up the total solution bringing up Intel comes in with their Intel® Edge Video Infrastructure (Intel® EVI) reference design. NEXCOM ran a bunch of tests using this design to evaluate its NSA 7160R for essential tasks including storage, image retrieval, and AI features such as inference and feature matching.
After conducting all tests, the results have shown that NSA 7160R meets all performance expectations with outstanding results. For a detailed breakdown of the solution description, test configuration, and results, please refer to the accompanying paper.
Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.
About NEXCOM
Founded in 1992 and headquartered in Taipei, Taiwan, NEXCOM integrates its diverse capabilities and operates six global businesses, including the Network and Communication Solutions (NCS) unit. NCS focuses on the latest network technology and helps to build reliable network infrastructure, by delivering professional design and manufacturing services for customers all over the world. NCS’s network application platform is widely adopted in Cyber Security, Load Balancing, 5G uCPE, SD-WAN, SASE, Edge Computing, OT Security, Storage, NVR, and other network applications for businesses of all sizes.
Video – https://www.youtube.com/watch?v=4WlO8fyWnu4

View original content:https://www.prnewswire.co.uk/news-releases/nexcom-delivers-exceptional-performance-in-edge-ai-video-analytics-302153555.html

Continue Reading

Artificial Intelligence

Qiming Venture Partners Promotes Alex Zhou to Managing Partner

Published

on

qiming-venture-partners-promotes-alex-zhou-to-managing-partner

SHANGHAI, May 23, 2024 /PRNewswire/ — Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner.

As a Qiming home-grown Managing Partner, Alex first joined the firm in 2014 as a Vice President and has since emerged as one of the most active investors in frontier technologies, especially in the field of artificial intelligence. Alex will join fellow Managing Partners Duane Kuang, Nisa Leung and William Hu in managing Qiming’s operations.
In the past few years, Alex has actively participated in or led investments in many outstanding technology companies across the artificial intelligence, robotics, semiconductors, new energy vehicles, and software sectors. Notable among these include Roborock, UBTech, Unisound, Biren Technology, ROX Motor, VIEWTRIX Technology, Zhipu AI, Mech-Mind Robotics, Axera, HyperStrong, DeepWay, etc.
“I am deeply grateful for the guidance and trust I received from Qiming over the past 10 years.” Alex said. “We are at the forefront of a new wave of technological revolution. This era will undoubtedly bring about many bold innovators who will shape the future. Together with all the Managing Partners and colleagues at Qiming, I am excited and fully committed to seize the opportunities, embrace any potential challenges, explore new possibilities and build a better Qiming.”
Since its inception 18 years ago, Qiming has always committed to upgrading its institutional capabilities and team development in order to stay ahead in an ever-evolving technological and market landscape. The success achieved in the fields of healthcare, mobile internet and frontier technology is a testament to this strategic approach. Alex’s promotion to the most senior position in the firm demonstrates Qiming’s continued confidence in the future of technology innovation.
About Qiming Venture Partners
Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.
Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, UBTech, Yuanxin Technology, Caidya, Belief BioMed, WeRide, among many others.

View original content:https://www.prnewswire.co.uk/news-releases/qiming-venture-partners-promotes-alex-zhou-to-managing-partner-302153306.html

Continue Reading

Trending